Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.

Abstract:

:The RAS-RAF-MEK-ERK signaling cascade is among the most frequently mutated pathways in human cancer. Approximately 50% of melanoma patients possess a druggable hotspot V600E/K mutation in the BRAF protein kinase. FDA-approved combination therapies of BRAF and MEK inhibitors are available that provide survival benefits to patients with a BRAF V600 mutation. Non-V600 BRAF mutants are found in many cancers, and are more prevalent than V600 mutations in certain tumor types. For example, between 50-80% of BRAF mutations in non-small cell lung cancer and 22-30% in colorectal cancer encode for non-V600 mutants. As next generation sequencing becomes increasingly used in clinical practice, oncologists are frequently identifying non-V600 BRAF mutations in their patient's tumors, but are uncertain of viable therapeutic options that could be employed for optimal treatment. From recent studies, a new classification system is emerging for BRAF mutations based on biochemical and signaling mechanisms associated with these mutants. Class I BRAF mutations affect amino acid V600 and signal as RAS-independent active monomers, class II mutations function as RAS-independent activated dimers, and class III mutations are kinase impaired but increase signaling through the MAPK pathway due to enhanced RAS binding and subsequent CRAF activation. These distinct classes of BRAF mutations predict response to targeted therapies and have important implications for future drug development. Herein, we discuss pre-clinical and clinical findings that may lead to improved treatments for all classes of BRAF mutant cancers.

journal_name

Oncogene

journal_title

Oncogene

authors

Dankner M,Rose AAN,Rajkumar S,Siegel PM,Watson IR

doi

10.1038/s41388-018-0171-x

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

3183-3199

issue

24

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-018-0171-x

journal_volume

37

pub_type

杂志文章,评审

相关文献

ONCOGENE文献大全
  • TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.

    abstract::The p14ARF tumor suppressor is a key regulator of cellular proliferation, frequently inactivated in human cancer. The mechanisms that regulate alternative reading frame (ARF) turnover have been obscure for long time, being ARF a relatively stable protein. Recently, it has been described that its degradation depends, a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210313

    authors: Pollice A,Sepe M,Villella VR,Tolino F,Vivo M,Calabrò V,La Mantia G

    更新日期:2007-08-02 00:00:00

  • Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.

    abstract::The tumor suppressor p53 transcriptionally regulates a large number of target genes that may affect cell growth and cell death pathways. To better understand the role of p53 loss in tumorigenesis, we have developed a mouse mammary cancer model, the Wnt-1 TG/p53 model. Wnt-1 transgenic females that are p53-/- develop m...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203993

    authors: Cui XS,Donehower LA

    更新日期:2000-12-07 00:00:00

  • NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.

    abstract::Low-grade glial neoplasms (astrocytomas) represent one of the most common brain tumors in the pediatric population. These tumors frequently form in the optic pathway (optic pathway gliomas, OPGs), especially in children with the neurofibromatosis type 1 (NF1)-inherited tumor predisposition syndrome. To model these tum...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.580

    authors: Solga AC,Gianino SM,Gutmann DH

    更新日期:2014-01-16 00:00:00

  • BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter.

    abstract::BCL11 genes play crucial roles in lymphopoiesis and have been associated with hematopoietic malignancies. Specifically, disruption of the BCL11B (B-cell chronic lymphocytic leukemia/lymphoma 11B) locus is linked to T-cell acute lymphoblastic leukemia, and the loss of heterozygosity in mice results in T-cell lymphoma. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208904

    authors: Cismasiu VB,Adamo K,Gecewicz J,Duque J,Lin Q,Avram D

    更新日期:2005-10-13 00:00:00

  • Role of basal calcium in the EGF activation of MAP kinases.

    abstract::The role of intracellular Ca2+ pools in the regulation of growth factor signal transduction pathways and mitogenesis is not well understood. We have examined the roles of basal and transiently mobilized Ca2+ in the regulation of MAP kinases by EGF. To assess the influence of Ca2+ transients we utilized Plcg1-/- and Pl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203517

    authors: Ji QS,Carpenter G

    更新日期:2000-03-30 00:00:00

  • The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.

    abstract::FUS (also called TLS), EWSR1 and TAF15 (also called TAF2N) are related genes involved in tumor type-specific fusion oncogenes in human malignancies. The FUS-DDIT3 fusion oncogene results from a t(12;16)(q13;p11) chromosome translocation and has a causative role in the initiation of myxoid/round cell liposarcomas (MLS/...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.378

    authors: Göransson M,Andersson MK,Forni C,Ståhlberg A,Andersson C,Olofsson A,Mantovani R,Aman P

    更新日期:2009-01-15 00:00:00

  • GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.

    abstract::Intraductal papillary mucinous neoplasm (IPMN), the most common pancreatic cystic neoplasm, is known to progress to invasive ductal adenocarcinoma. IPMNs commonly harbor activating somatic mutations in GNAS and KRAS, primarily GNAS(R201H) and KRAS(G12D). GNAS encodes the stimulatory G-protein α subunit (Gsα) that medi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.294

    authors: Taki K,Ohmuraya M,Tanji E,Komatsu H,Hashimoto D,Semba K,Araki K,Kawaguchi Y,Baba H,Furukawa T

    更新日期:2016-05-05 00:00:00

  • Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response.

    abstract::Retinoic Acid (RA) treatment induces disease remission of Acute Promyelocytic Leukaemia (APL) patients by triggering terminal differentiation of neoplastic cells. RA-sensitivity in APL is mediated by its oncogenic protein, which results from the recombination of the PML and the RA receptor alpha (RAR alpha) genes (PML...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203029

    authors: Grignani F,Gelmetti V,Fanelli M,Rogaia D,De Matteis S,Ferrara FF,Bonci D,Grignani F,Nervi C,Pelicci PG

    更新日期:1999-11-04 00:00:00

  • Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.

    abstract::The transcription factor activator protein-1 (AP-1) has been implicated in a large variety of biological processes including cell differentiation, proliferation, apoptosis and oncogenic transformation. It is thought that the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced AP-1 activity is because of the activation ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206102

    authors: Li J,Ma C,Huang Y,Luo J,Huang C

    更新日期:2003-01-16 00:00:00

  • Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a malignant hematopoietic disorder whose proliferative component is a result of RAS pathway deregulation caused by somatic mutation in the RAS or PTPN11 oncogenes or in patients with underlying neurofibromatosis type 1 (NF-1), by loss of NF1 gene function. To search for poten...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210361

    authors: Flotho C,Steinemann D,Mullighan CG,Neale G,Mayer K,Kratz CP,Schlegelberger B,Downing JR,Niemeyer CM

    更新日期:2007-08-23 00:00:00

  • Central roles of apoptotic proteins in mitochondrial function.

    abstract::Mitochondria have been classically characterized as organelles with responsibility for cellular energy production in the form of ATP, but they are also the organelles through which apoptotic signaling occurs. Cell stress stimuli can result in outer membrane permeabilization, after which mitochondria release numerous p...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.348

    authors: Kilbride SM,Prehn JH

    更新日期:2013-05-30 00:00:00

  • EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.

    abstract::Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overexpression has been implicated in MPNST formation, but its precise role and relevant signaling pathways remain unknown. We found that EGFR overexpression pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.579

    authors: Wu J,Patmore DM,Jousma E,Eaves DW,Breving K,Patel AV,Schwartz EB,Fuchs JR,Cripe TP,Stemmer-Rachamimov AO,Ratner N

    更新日期:2014-01-09 00:00:00

  • The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.

    abstract::The c-Jun NH2-terminal kinase (JNK) pathway represents one subgroup of MAP kinases that are activated primarily by cytokines and exposure to environmental stress. Autophagy is a protein-degradation system characterized by the formation of double-membrane vacuoles termed autophagosomes. Autophagy-related gene beclin 1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.441

    authors: Li DD,Wang LL,Deng R,Tang J,Shen Y,Guo JF,Wang Y,Xia LP,Feng GK,Liu QQ,Huang WL,Zeng YX,Zhu XF

    更新日期:2009-02-12 00:00:00

  • Function for p300 and not CBP in the apoptotic response to DNA damage.

    abstract::The cellular response to ionizing radiation (IR) includes the induction of apoptosis. The p300/CBP proteins possess histone acetyltransferase activity and function as transcriptional coactivators of p53. We have prepared cells deficient in p300 or CBP to define the roles of these proteins in the cellular response to D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202930

    authors: Yuan ZM,Huang Y,Ishiko T,Nakada S,Utsugisawa T,Shioya H,Utsugisawa Y,Shi Y,Weichselbaum R,Kufe D

    更新日期:1999-10-07 00:00:00

  • The c-myb proto-oncogene product binds to but does not activate the promoter of the DNA polymerase alpha gene.

    abstract::The myb proto oncogene product (c-Myb) is a transcriptional regulator and its expression and function are tightly linked to the cellular entry into S phase and DNA synthesis. It has been shown [Venturelli, D., Travali, S. & Calabretta, B. (1990). Proc. Natl. Acad. Sci. USA, 87, 5963-5967] that inhibition of T-cell pro...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sudo T,Miyazawa H,Hanaoka F,Ishii S

    更新日期:1992-10-01 00:00:00

  • Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta.

    abstract::Acute myeloid leukemia 1 (AML1) gene on chromosome 21 is involved in several chromosomal translocations, including t(8;21) and t(16;21), that produce chimeric fusion proteins AML1-eight twenty-one (ETO) and AML-myeloid transforming gene chromosome 16 (MTG16), which contribute to leukemogenesis. The molecular basis for...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209431

    authors: Qiu J,Wong J,Tweardy DJ,Dong S

    更新日期:2006-06-29 00:00:00

  • Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.

    abstract::Snail1 is a master regulator of the epithelial-mesenchymal transition (EMT) and has been implicated in key tumor biological processes such as invasion and metastasis. It has been previously shown that poly(ADP-ribose) polymerase-1 (PARP-1) knockdown, but not PARP inhibition, downregulates the expression of Snail1. In ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.153

    authors: Rodríguez MI,González-Flores A,Dantzer F,Collard J,de Herreros AG,Oliver FJ

    更新日期:2011-10-20 00:00:00

  • STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.

    abstract::Mutations in the c-KIT receptor occur somatically in many sporadic Gastrointestinal Stromal Tumors (GIST), and similar mutations have been identified at the germline level in kindreds with multiple GISTs. These mutations activate the tyrosine kinase activity of c-KIT and induce constitutive signaling. To investigate t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204704

    authors: Tuveson DA,Willis NA,Jacks T,Griffin JD,Singer S,Fletcher CD,Fletcher JA,Demetri GD

    更新日期:2001-08-16 00:00:00

  • Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma.

    abstract::To clarify the incidence, timing and pathogenetic significance of p53 gene alterations in the progression of small-cell lung carcinoma (SCLC), 17 primary tumors, 13 metastases and nine cell lines from 27 patients were analysed by a polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis. ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sameshima Y,Matsuno Y,Hirohashi S,Shimosato Y,Mizoguchi H,Sugimura T,Terada M,Yokota J

    更新日期:1992-03-01 00:00:00

  • NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21WAF1/CIP1 overexpression, which is reversed by metformin.

    abstract::Prevention and treatment options for hepatocellular carcinoma (HCC) are presently limited, underscoring the necessity for further elucidating molecular mechanisms underlying HCC development and identifying new prevention and therapeutic targets. Here, we demonstrate a unique protumorigenic niche in the livers of Ncoa5...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-1256-x

    authors: Williams M,Liu X,Zhang Y,Reske J,Bahal D,Gohl TG,Hollern D,Ensink E,Kiupel M,Luo R,Das R,Xiao H

    更新日期:2020-05-01 00:00:00

  • High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.

    abstract::We recently reported the cloning and overexpression of full-length forms of human fibroblast growth factor (FGF) receptors, bek and flg. These receptors contain three immunoglobulin (Ig)-like domains and an unusual acidic motif in the extracellular region, a single transmembrane segment and a protein tyrosine kinase c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crumley G,Bellot F,Kaplow JM,Schlessinger J,Jaye M,Dionne CA

    更新日期:1991-12-01 00:00:00

  • Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.

    abstract::Rhabdomyosarcoma (RMS) tumors are the most common soft-tissue sarcomas in childhood. In this investigation, we show that myostatin, a skeletal muscle-specific inhibitor of growth and differentiation is expressed and translated in the cultured RMS cell line, RD. The addition of exogenous recombinant myostatin inhibits ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207144

    authors: Langley B,Thomas M,McFarlane C,Gilmour S,Sharma M,Kambadur R

    更新日期:2004-01-15 00:00:00

  • Apoptosis is antagonized by large T antigens in the pathway to immortalization by polyomaviruses.

    abstract::The viability of rat embryo cells immortalized by thermosensitive mutants of SV40 or polyoma Large T antigen is impaired at the non-permissive temperature thus demonstrating that the immortal phenotype is dominantly maintained by Large T antigens. We have observed that exposing these cells to the restrictive temperatu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Zheng DQ,Vayssière JL,Petit PX,LeCoeur H,Spatz A,Mignotte B,Feunteun J

    更新日期:1994-11-01 00:00:00

  • Targeting the RB-E2F pathway in breast cancer.

    abstract::Mutations of the retinoblastoma tumor-suppressor gene (RB1) or components regulating the CDK-RB-E2F pathway have been identified in nearly every human malignancy. Re-establishing cell cycle control through cyclin-dependent kinase (CDK) inhibition has therefore emerged as an attractive option in the development of targ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.32

    authors: Johnson J,Thijssen B,McDermott U,Garnett M,Wessels LF,Bernards R

    更新日期:2016-09-15 00:00:00

  • Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.

    abstract::BRCA1 mutation carriers have an 85% lifetime risk of breast cancer and 60% for ovarian cancer. BRCA1 facilitates DNA double-strand break repair, and dysfunction of BRCA1 leads to hypersensitivity to DNA damaging agents and consequently genomic instability of cells. In this communication, we have examined the tumor inc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210451

    authors: Jeng YM,Cai-Ng S,Li A,Furuta S,Chew H,Chen PL,Lee EY,Lee WH

    更新日期:2007-09-13 00:00:00

  • The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD.

    abstract::Rel/NF-kappaB transcription factors are involved in several physiological processes, including the regulation of apoptosis. These factors were shown to exhibit pro- or anti-apoptotic activities in different cellular models, but at present, the mechanisms underlying these opposite effects are poorly understood. In this...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205536

    authors: Bernard D,Monte D,Vandenbunder B,Abbadie C

    更新日期:2002-06-27 00:00:00

  • Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins.

    abstract::Evi5 is a common site of retroviral integration in T-cell lymphomas of AKXD mice. Mapping studies have localized Evi5 to a region approximately 18 kb upstream of another common viral integration site, Gfi1, on mouse chromosome 5 (Liao X, Jenkins NA and Copeland NG, (1995a). J. Virol., 69, 7132-7137). Gfi1 encodes a zi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200929

    authors: Liao X,Du Y,Morse HC 3rd,Jenkins NA,Copeland NG

    更新日期:1997-03-06 00:00:00

  • Transcriptional regulation of A33 antigen expression by gut-enriched Krüppel-like factor.

    abstract::A33 antigen is a membrane-bound protein that is expressed only in intestinal epithelium and in most human colon cancers. Thus, A33 antigen has been explored as a potential therapeutic target for the treatment of colon cancers. However, little is known about the mechanism responsible for the tissue-specific pattern of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206508

    authors: Mao Z,Song S,Zhu Y,Yi X,Zhang H,Shang Y,Tong T

    更新日期:2003-07-10 00:00:00

  • The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.

    abstract::It has recently been shown that an adenovirus mutant lacking expression of the large E1B protein (deltaE1B) selectively replicates in p53 deficient cells. However, apart from the large E1B protein the adenovirus early region encodes the E1A and E4orf6 proteins which also have been reported to affect p53 expression as ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201540

    authors: Steegenga WT,Riteco N,Jochemsen AG,Fallaux FJ,Bos JL

    更新日期:1998-01-22 00:00:00

  • Activation of MyoD-dependent transcription by cdk9/cyclin T2.

    abstract::Myogenic transcription is repressed in myoblasts by serum-activated cyclin-dependent kinases, such as cdk2 and cdk4. Serum withdrawal promotes muscle-specific gene expression at least in part by down-regulating the activity of these cdks. Unlike the other cdks, cdk9 is not serum- or cell cycle-regulated and is instead...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205493

    authors: Simone C,Stiegler P,Bagella L,Pucci B,Bellan C,De Falco G,De Luca A,Guanti G,Puri PL,Giordano A

    更新日期:2002-06-13 00:00:00